切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2022, Vol. 16 ›› Issue (11) : 1050 -1053. doi: 10.3877/cma.j.issn.1674-0785.2022.11.004

所属专题: 指南共识

专家论坛

《中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)》基本问题解读
陈青1, 吴克瑾1,()   
  1. 1. 200011 上海,复旦大学附属妇产科医院乳腺科
  • 收稿日期:2022-05-31 出版日期:2022-11-15
  • 通信作者: 吴克瑾

Interpretation of basic contents of Clinical Practice China Guidelines for Breast Cancer during Pregnancy and Lactation (2022 edition)

Qing Chen1, Kejin Wu1,()   

  1. 1. Department of Breast Surgery, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200011, China
  • Received:2022-05-31 Published:2022-11-15
  • Corresponding author: Kejin Wu
引用本文:

陈青, 吴克瑾. 《中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)》基本问题解读[J]. 中华临床医师杂志(电子版), 2022, 16(11): 1050-1053.

Qing Chen, Kejin Wu. Interpretation of basic contents of Clinical Practice China Guidelines for Breast Cancer during Pregnancy and Lactation (2022 edition)[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1050-1053.

妊娠期与哺乳期乳腺癌由于生理上的改变以及诊疗措施可能对子代产生影响,其临床诊治具有独特性与复杂性。然而,国内相关研究较少且缺乏规范的临床诊治流程。中华医学会外科学分会乳腺外科学组组织编写的《中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)》参考GRADE系统标准将临床研究证据分类,优先选择Ⅰ类和Ⅱ类证据纳入评价体系,并结合中国临床研究特点和临床实践的可及性作出不同强度的推荐意见。本文对该指南中的基本问题进行解读,以期为国内乳腺外科医师临床工作提供参考。

Because of the physiological changes and the possible affection of diagnostic and treatment measures, the clinical management of breast cancer during pregnancy and lactation is unique and complex. However, there is only little related research and no standardized clinical diagnosis and treatment procedures exist in China. Therefore, the Chinese Society of Breast Surgery evaluated the level of evidence in clinical research of breast cancer during pregnancy and lactation by referring to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Based on the currently available high-quality level Ⅰ or Ⅱ evidence, the clinical characteristics of patients, and the accessibility of the clinical practice of breast surgery, the Clinical Practice Guideline for Breast Cancer during Pregnancy and Lactation 2022 was formulated. This article interprets the basic contents of the guidelines to provide reference for the clinical work of breast surgeons in China.

1
王富文, 傅少梅, 金玉春, 等. 妊娠期乳腺癌临床诊治回顾性分析 [J].中华外科杂志, 2018, 56(2):114-118.
2
吴克瑾. 从多学科协作入手加强妊娠期乳腺癌个案管理 [J].中华外科杂志, 2020, 58(2):95-98.
3
中华医学会外科学分会乳腺外科学组. 妊娠相关性乳腺癌临床诊治专家共识(2022版) [J]. 中华临床医师杂志(电子版), 2022, 14(5): 321-325.
4
Chen Q, Qiu YR, Zhang MD, et al. Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021 [J]. Chin Med J (Engl), 2021, 134(20):2395-2397.
5
中华医学会外科学分会乳腺外科学组. 中国妊娠期与哺乳期乳腺癌临床实践指南(2022版) [J].中国实用外科杂志, 2022, 42(2):146-150.
6
Amant F, Lefrère H, Borges VF, et al. The definition of pregnancy-associated breast cancer is outdated and should no longer be used [J]. Lancet Oncol, 2021, 22(6):753-754.
7
Jerzak KJ, Lipton N, Nofech-Mozes S, et al. Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study [J]. Breast Cancer Res Treat, 2021, 189(3):797-806.
8
Sun J, Lee MC. Clinical presentation, diagnosis and prognosis of pregnancy-associated breast cancer [J]. Adv Exp Med Biol, 2020, 1252:87-93.
9
Viswanathan S, Ramaswamy B. Pregnancy-associated breast cancer [J]. Clin Obstet Gynecol, 2011, 54(4):546-555.
10
Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation [J]. Obstet Gynecol, 2017, 130(4):e210-e216.
11
Robbins J, Jeffries D, Roubidoux M, et al. Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation [J]. AJR Am J Roentgenol, 2011, 196(3):716-722.
12
Torloni MR, Vedmedovska N, Merialdi M, et al. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis [J]. Ultrasound Obstet Gynecol, 2009, 33(5):599-608.
13
Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy [J]. Lancet, 2012, 379(9815):570-579.
14
Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients [J]. JAMA Oncol, 2015, 1(8):1145-1153.
15
Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? [J]. J Clin Pathol, 2001, 54(10):762-765.
16
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (2022-Breast Version 2) [EB/OL]. [2021-12-20].

URL    
17
Peccatori FA, Azim HAJr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2013, 24 Suppl 6:vi160-170.
18
Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy [J]. Oncologist, 2017, 22(3):324-334.
19
Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes [J]. JAMA, 2016, 316(9):952-961.
20
马田雨, 代文杰. 妊娠期乳腺癌诊断及治疗进展 [J].中国实用外科杂志, 2014,(4):376-378.
21
Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals [J]. J Clin Oncol, 2005, 23(18):4192-4197.
22
Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy [J]. N Engl J Med, 2015, 373(19):1824-1834.
23
>ACOG Committee Opinion No. 775: Nonobstetric Surgery During Pregnancy [J]. Obstet Gynecol, 2019, 133(4):e285-e286.
24
Arkenbosch J, van Ruler O, de Vries AC. Non-obstetric surgery in pregnancy (including bowel surgery and gallbladder surgery) [J]. Best Pract Res Clin Gastroenterol, 2020, 44-45:101669.
25
Tolcher MC, Fisher WE, Clark SL. Nonobstetric Surgery During Pregnancy [J]. Obstet Gynecol, 2018, 132(2):395-403.
26
Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl):7S-47S.
27
Upadya M, Saneesh PJ. Anaesthesia for non-obstetric surgery during pregnancy [J]. Indian J Anaesth, 2016, 60(4):234-241.
28
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 171: Management of Preterm Labor [J]. Obstet Gynecol, 2016, 128(4):e155-164.
29
Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study [J]. Lancet Oncol, 2012, 13(9):887-896.
30
Annane K, Bellocq JP, Brettes JP, et al. Infiltrative breast cancer during pregnancy and conservative surgery [J]. Fetal Diagn Ther, 2005, 20(5):442-444.
31
Gentilini O, Cremonesi M, Trifirò G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer [J]. Ann Oncol, 2004, 15(9):1348-1351.
32
Pandit-Taskar N, Dauer LT, Montgomery L, et al. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients [J]. J Nucl Med, 2006, 47(7):1202-1208.
33
Gentilini O, Cremonesi M, Toesca A, et al. Sentinel lymph node biopsy in pregnant patients with breast cancer [J]. Eur J Nucl Med Mol Imaging, 2010, 37(1):78-83.
34
Bae SY, Kim KS, Kim JS, et al. Neoadjuvant chemotherapy and prognosis of pregnancy-associated breast cancer: a time-trends study of the Korean Breast Cancer Registry Database [J]. J Breast Cancer, 2018, 21(4):425-432.
35
Peccatori FA, Lambertini M, Scarfone G, et al. Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences [J]. Cancer Biol Med, 2018, 15(1):6-13.
36
Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients [J]. Ann Oncol, 2004, 15(1):146-150.
37
Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study [J]. Lancet Oncol, 2012, 13(3):256-264.
38
de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients [J]. Lancet Oncol, 2018, 19(3):337-346.
39
National Toxicology Program. NTP Monograph: Developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy [J]. NTP Monogr, 2013,(2):i-214.
40
Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy [J]. Lancet Oncol, 2004, 5(5):283-291.
41
Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding? [J]. Cancer Treat Rev, 2013, 39(3):207-211.
42
Griffin SJ, Milla M, Baker TE, et al. Transfer of carboplatin and paclitaxel into breast milk [J]. J Hum Lact, 2012, 28(4):457-459.
43
吴克瑾, 陈玉芸, 金玉春, 等. 年轻女性早期乳腺癌病人生育相关调查研究 [J].中国实用外科杂志, 2021, 41(11):1262-1268.
44
ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, et al. ESHRE guideline: female fertility preservation [J]. Hum Reprod Open, 2020, 2020(4):hoaa052.
45
Gundelach T, Stuck D, Widschwendter P, et al. Fertility preservation after caesarean delivery in a woman diagnosed with Morbus Hodgkin disease during pregnancy [J]. J Assist Reprod Genet, 2014, 31(1):51-53.
46
Pereira N, Kligman I, Hunt R, et al. Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer [J]. Gynecol Endocrinol, 2019, 35(3):214-216.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 邵华, 那子悦, 荆慧, 李博, 王秋程, 程文. 术前经皮超声造影对乳腺癌腋窝前哨淋巴结转移及负荷的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 849-853.
[3] 张旭, 徐建平, 苏冬明, 王彩芬, 王大力, 张文智. 男性乳腺肿块的超声造影特征[J]. 中华医学超声杂志(电子版), 2023, 20(08): 854-859.
[4] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[5] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[6] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[7] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[8] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[9] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[10] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[11] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[12] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[13] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
[14] 刘飞, 王影新, 马骍, 辛灵, 程元甲, 刘倩, 王悦, 张军军. 不同介质腔内心电图定位技术在乳腺癌上臂输液港植入术中应用的随机对照研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 760-764.
[15] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
阅读次数
全文


摘要